Major Adverse Cognitive Events (MACE-Cog): A New “MACE” Framework for Cognitive Outcomes in Cardiovascular Diseases and Stroke

A Aravind Ganesh (Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, AB, Canada) S Sajeevan Sujanthan (Institute of Medical Sciences, ON, Canada (S.S., R.T.M., R.H.S.)) R Ryan T. Muir (Institute of Medical Sciences, ON, Canada (S.S., R.T.M., R.H.S.)) R Raed A. Joundi (McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada) M Michael D. Hill (Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Foothills Medical Centre, Calgary, AB, Canada) T Terence J. Quinn (School of Cardiovascular and Metabolic Health, University of Glasgow, UK (T.J.Q.).) B Bijoy Menon (Calgary Stroke Program, Departments of Clinical Neurosciences, Radiology, Medicine, and Community Health Sciences; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, and O’Brien Institute for Public Health; University of Calgary Cumming School of Medicine, AB, Canada (A.G., M.D.H., B.M., T.S., E.E.S.)) T Tolulope Sajobi (Calgary Stroke Program, Departments of Clinical Neurosciences, Radiology, Medicine, and Community Health Sciences; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, and O’Brien Institute for Public Health; University of Calgary Cumming School of Medicine, AB, Canada (A.G., M.D.H., B.M., T.S., E.E.S.)) J Jennifer S. Rabin (Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre (J.S.R., S.S., R.T.M., R.H.S.)) K Katie N. Dainty M Morgan D. Barense (Department of Psychology, ON, Canada (M.D.B.)) K Krista L. Lanctôt (Department of Psychiatry, Sunnybrook Health Sciences Centre, ON, Canada (K.L.L.)) J James Kennedy (Acute Multidisciplinary Imaging and Interventional Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom) R Rajesh K. Kharbanda (Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom) D Douglas S. Lee M Mario F.L. Gaudio (Weill Cornell Medicine, New York, NY (M.F.G.).) S Stephen Fremes (Institute of Health Policy, Management and Evaluation, ON, Canada (K.N.D., S.F.)) R Ruth M. Masterson Creber (Columbia University School of Nursing, Columbia University Irving Medical Center, New York, NY (R.M.M.C.).) E Eric E. Smith R Richard H. Swartz (Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto)

Abstract

Cardiovascular diseases, particularly stroke, are leading causes of dementia. Several common cardiac interventions such as coronary artery bypass grafting and transcatheter aortic valve implantation are also associated with cognitive decline. However, cognitive outcomes continue to be poorly collected in clinical trials of cardiovascular diseases. In this article, we review the limitations of current approaches to cognitive assessment in cardiovascular disease studies. When assessed, there is wide variation in cognitive tasks used, and tasks have limited population-specific validation, are subject to floor and ceiling effects, and may suffer from sociocultural and linguistic biases. Many tasks are not available in multilingual formats and often rely on face-to-face testing with trained coordinators. All conventional cognitive outcomes in cardiovascular trials are associated with substantial incompletion, especially among older and more impaired individuals, the very people most important to capture. This nonrandom missingness generates survivor and attrition biases, an unacceptable situation for any trial outcome. Last, the meaning of measured cognitive outcomes is often unclear for patients, caregivers, clinicians, and regulators. To help address these limitations, we propose a new framework, major adverse cognitive events (MACE-Cog), to better capture cognitive outcomes in stroke and other cardiovascular populations. As an inclusive construct reflecting the multidimensional nature of cognitive decline, major adverse cognitive events do not rely solely on performance on cognitive testing but also consider inability to complete cognitive testing due to cognitive-behavioral factors, reported symptoms of cognitive decline, impairment in activities of daily living as a result of cognitive impairment, new clinical diagnoses of dementia, and care home admission. We hope that the proposed composite outcome and multiple use cases presented spark progress in cardiovascular research toward more inclusive approaches to the study of cognitive outcomes that move beyond the confines of cognitive tests alone.

Article Details

Journal Circulation
Volume / Issue Vol. 154, Issue 4
Published July 28, 2026
Pages 378-394
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (20)

A

Aravind Ganesh

Department of Clinical Neurosciences, University of Calgary Cumming School of Medicine, Calgary, AB, Canada

S

Sajeevan Sujanthan

Institute of Medical Sciences, ON, Canada (S.S., R.T.M., R.H.S.)

R

Ryan T. Muir

Institute of Medical Sciences, ON, Canada (S.S., R.T.M., R.H.S.)

R

Raed A. Joundi

McMaster University, Population Health Research Institute, Hamilton Health Sciences, Hamilton, ON, Canada

M

Michael D. Hill

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary and Foothills Medical Centre, Calgary, AB, Canada

T

Terence J. Quinn

School of Cardiovascular and Metabolic Health, University of Glasgow, UK (T.J.Q.).

B

Bijoy Menon

Calgary Stroke Program, Departments of Clinical Neurosciences, Radiology, Medicine, and Community Health Sciences; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, and O’Brien Institute for Public Health; University of Calgary Cumming School of Medicine, AB, Canada (A.G., M.D.H., B.M., T.S., E.E.S.)

T

Tolulope Sajobi

Calgary Stroke Program, Departments of Clinical Neurosciences, Radiology, Medicine, and Community Health Sciences; Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education, and O’Brien Institute for Public Health; University of Calgary Cumming School of Medicine, AB, Canada (A.G., M.D.H., B.M., T.S., E.E.S.)

J

Jennifer S. Rabin

Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre (J.S.R., S.S., R.T.M., R.H.S.)

K

Katie N. Dainty

M

Morgan D. Barense

Department of Psychology, ON, Canada (M.D.B.)

K

Krista L. Lanctôt

Department of Psychiatry, Sunnybrook Health Sciences Centre, ON, Canada (K.L.L.)

J

James Kennedy

Acute Multidisciplinary Imaging and Interventional Centre, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

R

Rajesh K. Kharbanda

Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

D

Douglas S. Lee

M

Mario F.L. Gaudio

Weill Cornell Medicine, New York, NY (M.F.G.).

S

Stephen Fremes

Institute of Health Policy, Management and Evaluation, ON, Canada (K.N.D., S.F.)

R

Ruth M. Masterson Creber

Columbia University School of Nursing, Columbia University Irving Medical Center, New York, NY (R.M.M.C.).

E

Eric E. Smith

R

Richard H. Swartz

Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto